Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
2403
mi
from 98109
New York, NY
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
2403
mi
from 98109
New York, NY
Click here to add this to my saved trials
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated:  12/31/1969
MetroHealth Med Ctr
2020
mi
from 98109
Cleveland, OH
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated: 12/31/1969
MetroHealth Med Ctr
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated:  12/31/1969
University Hospitals
2024
mi
from 98109
Cleveland, OH
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated: 12/31/1969
University Hospitals
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated:  12/31/1969
UNC Chapel Hill
2329
mi
from 98109
CHapel Hill, NC
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill
2329
mi
from 98109
CHapel Hill, NC
Click here to add this to my saved trials
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Jasper Summit Research, LLC
2044
mi
from 98109
Jasper, AL
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Jasper Summit Research, LLC
2044
mi
from 98109
Jasper, AL
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Pulmonary Associates, PA
1115
mi
from 98109
Phoenix, AZ
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Pulmonary Associates, PA
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of California
962
mi
from 98109
Los Angeles, CA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of California
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of California
682
mi
from 98109
San Francisco, CA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of California
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Sansum Clinic
921
mi
from 98109
Santa Barbara, CA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Sansum Clinic
921
mi
from 98109
Santa Barbara, CA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of California
976
mi
from 98109
Torrance, CA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of California
976
mi
from 98109
Torrance, CA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Western Connecticut Medical Group PC
2406
mi
from 98109
Danbury, CT
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Western Connecticut Medical Group PC
2406
mi
from 98109
Danbury, CT
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Pulmonary Assoc of Stamford
2411
mi
from 98109
Stamford, CT
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Pulmonary Assoc of Stamford
2411
mi
from 98109
Stamford, CT
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
2710
mi
from 98109
Weston, FL
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2710
mi
from 98109
Weston, FL
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Georgia Clinical Research
2164
mi
from 98109
Austell, GA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Georgia Clinical Research
2164
mi
from 98109
Austell, GA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of Chicago
1737
mi
from 98109
Chicago, IL
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of Chicago
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Via Christi Clinic
1450
mi
from 98109
Wichita, KA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Via Christi Clinic
1450
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Baptist Health Lexington
2004
mi
from 98109
Lexington, KY
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Baptist Health Lexington
2004
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Minnesota Lung Center
1392
mi
from 98109
Minneapolis, MN
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Minnesota Lung Center
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
The Lung Research Center
1706
mi
from 98109
Chesterfield, MO
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
The Lung Research Center
1706
mi
from 98109
Chesterfield, MO
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Pulmonary and Critical Care Associates
mi
from 98109
Albany, NY
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Pulmonary and Critical Care Associates
mi
from 98109
Albany, NY
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Jamaica Hospital Medical Center
2410
mi
from 98109
Jamaica, NY
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Jamaica Hospital Medical Center
2410
mi
from 98109
Jamaica, NY
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital
2400
mi
from 98109
New York, NY
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
1967
mi
from 98109
Cincinnati, OH
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
ID Clinical Research, Ltd.
1929
mi
from 98109
Toledo, OH
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
ID Clinical Research, Ltd.
1929
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Oregon Clinic
146
mi
from 98109
Portland, OR
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Oregon Clinic
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
2486
mi
from 98109
Providence, RI
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
FDC Seifer PLC Pulmonary
mi
from 98109
Shelbyville, TN
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
FDC Seifer PLC Pulmonary
mi
from 98109
Shelbyville, TN
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
DCOL Center for Clinical Research
1778
mi
from 98109
Longview, TX
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
DCOL Center for Clinical Research
1778
mi
from 98109
Longview, TX
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Metroplex Pul and Sleep Ctr
1668
mi
from 98109
McKinney, TX
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Metroplex Pul and Sleep Ctr
1668
mi
from 98109
McKinney, TX
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Diagnostics Research Group
1779
mi
from 98109
San Antonio, TX
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Diagnostics Research Group
1779
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Vermont Lung Center
2324
mi
from 98109
Colchester, VT
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Vermont Lung Center
2324
mi
from 98109
Colchester, VT
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
2314
mi
from 98109
Falls Church, VA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
2314
mi
from 98109
Falls Church, VA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Lynchburg Pulmonary Associates
2276
mi
from 98109
Lynchburg, VA
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Lynchburg Pulmonary Associates
2276
mi
from 98109
Lynchburg, VA
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
1616
mi
from 98109
Madison, WI
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  12/31/1969
Royal Prince Alfred Hospital
7750
mi
from 98109
Camperdown,
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 12/31/1969
Royal Prince Alfred Hospital
7750
mi
from 98109
Camperdown,
Click here to add this to my saved trials
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)
A Novel Assay to Quantify Treatment Response in CF
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
1022
mi
from 98109
Denver, CO
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)
A Novel Assay to Quantify Treatment Response in CF
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
1022
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
TITLE: Double-blinded, Double-dummy, Study Comparing Fluticasone-salmeterol to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.
Status: Enrolling
Updated:  12/31/1969
Penn State Universuty
2294
mi
from 98109
Hershey, PA
Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
TITLE: Double-blinded, Double-dummy, Study Comparing Fluticasone-salmeterol to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.
Status: Enrolling
Updated: 12/31/1969
Penn State Universuty
2294
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
University of Wisconsin Meditation & Exercise Cold Study
Meditation or Exercise for Preventing Acute Respiratory Infection (MEPARI-2)
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Department of Family Medicine
1617
mi
from 98109
Madison, WI
University of Wisconsin Meditation & Exercise Cold Study
Meditation or Exercise for Preventing Acute Respiratory Infection (MEPARI-2)
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Department of Family Medicine
1617
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2)
Status: Enrolling
Updated:  12/31/1969
205.452.01041 Boehringer Ingelheim Investigational Site
2151
mi
from 98109
Montgomery, AL
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2)
Status: Enrolling
Updated: 12/31/1969
205.452.01041 Boehringer Ingelheim Investigational Site
2151
mi
from 98109
Montgomery, AL
Click here to add this to my saved trials
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2)
Status: Enrolling
Updated:  12/31/1969
205.478.00208 Boehringer Ingelheim Investigational Site
1020
mi
from 98109
Flagstaff, AZ
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2)
Status: Enrolling
Updated: 12/31/1969
205.478.00208 Boehringer Ingelheim Investigational Site
1020
mi
from 98109
Flagstaff, AZ
Click here to add this to my saved trials